LINE Quote, Financials, Valuation and Earnings

EastGroup Properties, Inc. has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 36.76%. Lineage, Inc.'s return on equity of -2.03% beat EastGroup Properties, Inc.'s return on equity of 7.58%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 11.24%. On the other hand EastGroup Properties, Inc. has an analysts' consensus of $199.84 which suggests that it could grow by 11.05%. Given that Lineage, Inc. has higher upside potential than EastGroup Properties, Inc., analysts believe Lineage, Inc. is more attractive than EastGroup Properties, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison EastGroup Properties, Inc. has a beta of 1.113, suggesting its more volatile than the S&P 500 by 11.321%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.95%. EastGroup Properties, Inc. offers a yield of 3.28% to investors and pays a quarterly dividend of $1.55 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. EastGroup Properties, Inc. pays out 114.68% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but EastGroup Properties, Inc.'s is not.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than EastGroup Properties, Inc. quarterly revenues of $182.1M. Lineage, Inc.'s net income of -$112M is lower than EastGroup Properties, Inc.'s net income of $67M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while EastGroup Properties, Inc.'s PE ratio is 37.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.51x versus 13.42x for EastGroup Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Peakstone Realty Trust has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 68.74%. Lineage, Inc.'s return on equity of -2.03% beat Peakstone Realty Trust's return on equity of -31.39%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 11.24%. On the other hand Peakstone Realty Trust has an analysts' consensus of $17.00 which suggests that it could grow by 21.69%. Given that Peakstone Realty Trust has higher upside potential than Lineage, Inc., analysts believe Peakstone Realty Trust is more attractive than Lineage, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Peakstone Realty Trust has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.95%. Peakstone Realty Trust offers a yield of 4.65% to investors and pays a quarterly dividend of $0.10 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Peakstone Realty Trust pays out 291.09% of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Peakstone Realty Trust's is not.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Peakstone Realty Trust quarterly revenues of $25.8M. Lineage, Inc.'s net income of -$112M is lower than Peakstone Realty Trust's net income of $17.7M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Peakstone Realty Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.51x versus 2.63x for Peakstone Realty Trust. Usually stocks with elevated PS ratios are considered overvalued.

Symmetry Medical, Inc. has a net margin of -8.13% compared to Lineage, Inc.'s net margin of --. Lineage, Inc.'s return on equity of -2.03% beat Symmetry Medical, Inc.'s return on equity of --.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 11.24%. On the other hand Symmetry Medical, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Lineage, Inc. has higher upside potential than Symmetry Medical, Inc., analysts believe Lineage, Inc. is more attractive than Symmetry Medical, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Symmetry Medical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.95%. Symmetry Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Symmetry Medical, Inc. pays out -- of its earnings as a dividend. Lineage, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Symmetry Medical, Inc. quarterly revenues of --. Lineage, Inc.'s net income of -$112M is higher than Symmetry Medical, Inc.'s net income of --. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Symmetry Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.51x versus -- for Symmetry Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Veris Residential, Inc. has a net margin of -8.13% compared to Lineage, Inc.'s net margin of 15.63%. Lineage, Inc.'s return on equity of -2.03% beat Veris Residential, Inc.'s return on equity of 5.02%.

Lineage, Inc. has a consensus price target of $39.44, signalling upside risk potential of 11.24%. On the other hand Veris Residential, Inc. has an analysts' consensus of $17.58 which suggests that it could grow by 18.01%. Given that Veris Residential, Inc. has higher upside potential than Lineage, Inc., analysts believe Veris Residential, Inc. is more attractive than Lineage, Inc..

Lineage, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Veris Residential, Inc. has a beta of 1.252, suggesting its more volatile than the S&P 500 by 25.214%.

Lineage, Inc. has a quarterly dividend of $0.53 per share corresponding to a yield of 5.95%. Veris Residential, Inc. offers a yield of 2.15% to investors and pays a quarterly dividend of $0.08 per share. Lineage, Inc. pays 30.35% of its earnings as a dividend. Veris Residential, Inc. pays out 87.38% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Lineage, Inc. quarterly revenues are $1.4B, which are larger than Veris Residential, Inc. quarterly revenues of $73.4M. Lineage, Inc.'s net income of -$112M is lower than Veris Residential, Inc.'s net income of $77.5M. Notably, Lineage, Inc.'s price-to-earnings ratio is -- while Veris Residential, Inc.'s PE ratio is 22.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lineage, Inc. is 1.51x versus 4.99x for Veris Residential, Inc.. Usually stocks with elevated PS ratios are considered overvalued.